M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations
Lyell Immunopharma, Inc. to acquire ImmPACT Bio
Announced Oct 24, 2024 · Closed Oct 31, 2024 · Private target
Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationCash and stock
Transaction
- Acquirer
- Lyell Immunopharma, Inc. (LYEL)
- Target
- ImmPACT Bio
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Oct 31, 2024
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Goldman Sachs
- To the target
- Not disclosed
Classification
- Sector
- Healthcare
- Buyer's industry
- Pharmaceutical Preparations